10212025

The chart shows the growth of an initial investment of $10,000 in 10212025, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Dec 14, 2016, 10212025's average daily return is +0.08%, while the average monthly return is +1.64%. At this rate, an investment would double in approximately 3.6 years.

Historically, 70% of months were positive and 30% were negative. The best month was Aug 2020 with a return of +17.7%, while the worst month was Mar 2020 at -11.4%. The longest winning streak lasted 14 consecutive months, and the longest losing streak was 3 months.

On a daily basis, 10212025 closed higher 56% of trading days. The best single day was Mar 24, 2020 with a return of +8.0%, while the worst single day was Mar 16, 2020 at -8.9%.

10212025 has an annualized alpha of 9.51%, beta of 0.76, and R2 of 0.72 versus S&P 500 Index. Calculated based on daily prices since December 14, 2016.

• This portfolio participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (97.43%) than losses (64.63%) - typical of diversified or defensive assets.
• This portfolio generated an annualized alpha of 9.51% versus S&P 500 Index - delivering returns beyond what market exposure alone would predict.

10212025 has an expense ratio of 0.23%, which is considered low. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

10212025 ranks 37 for risk / return — below 37% of Portfolios on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

The current 10212025 Sharpe ratio is 1.73 as of Jun 13, 2026 (the value is recalculated daily), calculated over the past 12 months.

Compared to the broad market, where average Sharpe ratios range from 1.53 to 2.41, this portfolio's current Sharpe ratio falls between the 25th and 75th percentiles. This indicates that its risk-adjusted performance is in line with the majority of portfolios, suggesting a balanced approach to risk and return—likely suitable for a wide range of investors.

The chart below shows the rolling Sharpe ratio of 10212025 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

10212025 provided a 3.50% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the 10212025. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the 10212025 was 31.81%, occurring on Mar 18, 2020. Recovery took 75 trading sessions.

The current 10212025 drawdown is 1.76%.

The chart below shows the rolling one-month volatility.